Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle Biopsy

BackgroundThe purpose of this study was to determine whether surgical excision of benign solitary intraductal papillomas (BSIP) diagnosed by core needle biopsy (CNBx) without an associated high-risk lesion and concordant with imaging is justified.MethodsA review of all papillary lesions diagnosed by CNBx from January 2003 to June 2010 was performed. Available histologic and radiologic materials were evaluated in a blinded fashion by three pathologists and three dedicated breast radiologists, respectively, to assess for concordance. The papillary lesions were designated as benign, atypical, or malignant. There were 16 BSIPs excluded because of an adjacent high-risk lesion or same-quadrant ipsilateral cancer. All immediate and delayed excisional specimens were reviewed. Clinical and radiologic data were recorded.ResultsA total of 299 papillary lesions diagnosed on CNBx and concordant with imaging were identified. Of these, 240 (80 %) were classified as benign, 49 (16 %) atypical, and 10 (3 %) malignant. After exclusions, 77 of 224 women in our study cohort (34 %) underwent surgical excision with no atypical or malignant upgrades. Of the remaining 147 women diagnosed with a BSIP on CNBx, 47 (32 %) were lost to follow-up and 100 (68 %) were observed. All 100 observed patients had stable imaging findings at follow-up (4.8–93.8 months, mean 36.0 months).ConclusionsThe likelihood of diagnosing atypia or malignancy after surgical excision of a BSIP diagnosed on CNBx without associated high-risk lesion or ipsilateral quadrant malignancy is extremely low. For this distinct subset of patients with a BSIP, these data justify close imaging follow-up, rather than surgical excision.

[1]  W. Wood,et al.  Surgical Follow-Up and Clinical Presentation of 142 Breast Papillary Lesions Diagnosed by Ultrasound-Guided Core-Needle Biopsy , 2008, Annals of Surgical Oncology.

[2]  S. Schnitt,et al.  Nonmalignant Lesions in Breast Core Needle Biopsies: To Excise or Not to Excise? , 2002, The American journal of surgical pathology.

[3]  L. Liberman,et al.  Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? , 2006, AJR. American journal of roentgenology.

[4]  R. Vierkant,et al.  An Analysis of Breast Cancer Risk in Women With Single, Multiple, and Atypical Papilloma , 2006, The American journal of surgical pathology.

[5]  A. Mulligan,et al.  Papillary Lesions of the Breast: Impact of Breast Pathology Subspecialization on Core Biopsy and Excision Diagnoses , 2012, The American journal of surgical pathology.

[6]  S. Jaffer,et al.  Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy , 2009, Cancer.

[7]  S. Raza,et al.  Management of Intraductal Papillomas of the Breast: An Analysis of 129 Cases and Their Outcome , 2009, Annals of Surgical Oncology.

[8]  J. Youk,et al.  The diagnosis of non-malignant papillary lesions of the breast: comparison of ultrasound-guided automated gun biopsy and vacuum-assisted removal. , 2011, Clinical radiology.

[9]  L. Collins,et al.  Papillary lesions of the breast: selected diagnostic and management issues , 2007, Histopathology.

[10]  Eun Sook Ko,et al.  Korea. Address reprint requests to: , 2005 .

[11]  S. Feldman,et al.  Papillary Lesions: A Review of the Literature , 2007, Annals of Surgical Oncology.

[12]  S. Gabram,et al.  Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. , 2012, Journal of the American College of Surgeons.

[13]  J. Baker,et al.  Is surgical excision of core biopsy proven benign papillomas of the breast necessary? , 2010, Academic radiology.

[14]  D. Georgian-Smith,et al.  Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective. , 2010, Radiologic clinics of North America.

[15]  J. Cangiarella,et al.  Papillary lesions of the breast at percutaneous core-needle biopsy. , 2006, Radiology.

[16]  L. Liberman,et al.  Percutaneous large-core biopsy of papillary breast lesions. , 1999, AJR. American journal of roentgenology.

[17]  C. Lee,et al.  Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. , 2000, Radiology.

[18]  A. Renshaw,et al.  Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. , 2004, American journal of clinical pathology.

[19]  T. Hijaz,et al.  Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. , 2007, Radiology.

[20]  D. Noh,et al.  Papillary Lesions Initially Diagnosed at Ultrasound-guided Vacuum-assisted Breast Biopsy: Rate of Malignancy Based on Subsequent Surgical Excision , 2011, Annals of Surgical Oncology.

[21]  C. Denkert,et al.  Intraductal papillomas of the breast: diagnosis and management of 151 patients. , 2011, Breast.

[22]  C. Mercado,et al.  Papillary lesions of the breast: evaluation with stereotactic directional vacuum-assisted biopsy. , 2001, Radiology.

[23]  C. Chen,et al.  Risk Factors Associated with Conversion from Nonmalignant to Malignant Diagnosis After Surgical Excision of Breast Papillary Lesions , 2009, Annals of Surgical Oncology.

[24]  Mary Scott Soo,et al.  Imaging-guided core needle biopsy of papillary lesions of the breast. , 2002, AJR. American journal of roentgenology.

[25]  W. Dupont,et al.  Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma , 1996, Cancer.